Xilio Therapeutics, Inc.

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Timothy P Clackson. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Timothy P Clackson reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ELEV / Elevation Oncology, Inc. Director 0
US: / THESEUS PHARMACEUTICALS INC President and CEO, Director 351,030
US:FMTX / Forma Therapeutics Holdings Inc Director 0
US:XLO / Xilio Therapeutics, Inc. 10% Owner 20,068
US:849CVR014 / CVR F STAR Director 50,486
US:ARIA / ARIAD Pharmaceuticals, Inc. President, R&D, CSO 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Timothy P Clackson. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas XLO / Xilio Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em XLO / Xilio Therapeutics, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

XLO / Xilio Therapeutics, Inc. Insider Trades
Vendas Internas XLO / Xilio Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em XLO / Xilio Therapeutics, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

XLO / Xilio Therapeutics, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Timothy P Clackson conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-07-24 2025-07-23 4 ELEV Elevation Oncology, Inc.
Common Stock
U - Other -47,330 0 -100.00 0.36 -17,039
2023-09-05 2023-09-01 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -15,777 0 -100.00
2022-11-14 2022-11-11 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,500 351,030 0.72 6.80 16,995 2,386,302
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -7,250 0 -100.00
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -23,590 0 -100.00
2022-06-22 2022-05-31 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -31,553 15,777 -66.67
2022-06-09 2022-06-08 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 4,500 30,840 17.08
2022-02-23 2022-02-18 4 THRX Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 450,000 450,000
2021-12-22 2021-12-21 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,600 348,530 0.75 9.76 25,381 3,402,385
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
20,068
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
70,888
2021-10-06 3 THRX Theseus Pharmaceuticals, Inc.
Common Stock
345,930
2021-06-24 3 ELEV Elevation Oncology, Inc.
Common Stock
47,330
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 8,375 8,375
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 2,750 26,340 11.66
2020-10-01 2020-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 9,422 50,486 22.94
2020-07-01 2020-06-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 8,588 41,064 26.44
2020-06-25 2020-06-24 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
S - Sale -35,067 0 -100.00
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Common Stock
P - Purchase 23,590 23,590
2020-06-22 2020-06-18 4 FMTX Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy)
A - Award 17,533 0 -100.00
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-04-01 2020-03-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 13,575 32,476 71.82
2020-01-02 2019-12-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 7,991 18,901 73.24
2019-10-01 2019-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,670 10,910 50.69
2019-07-11 2019-07-10 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2019-07-01 2019-06-28 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,421 7,240 89.58
2019-04-02 2019-03-29 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,204 3,819 46.04
2019-01-03 2019-01-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,083 2,615 70.69
2018-10-02 2018-10-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 788 1,532 105.91
2018-07-03 2018-07-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 744 744
2018-03-05 2018-03-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 11,000 11,000
2018-03-05 3 SBPH Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned
0
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -14,550 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -72,980 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -87,125 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -65,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -82,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -577 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -219,867 0 -100.00
2017-02-07 2017-02-06 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 14,550 14,550
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 0 -100.00
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -9,610 219,867 -4.19 23.82 -228,886 5,236,682
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 229,477 14.66
2016-10-25 2016-10-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,638 197,884 -9.03 9.56 -187,739 1,891,771
2016-09-28 2016-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 217,522 -3.87 13.98 -122,311 3,040,610
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 0 -100.00
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 226,272 8.38
2016-09-23 2016-09-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 208,772 -8.74 13.43 -268,536 2,803,140
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -59,369 0 -100.00
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -59,369 228,772 -20.60 11.73 -696,398 2,683,496
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 59,369 288,141 25.95 7.82 464,266 2,253,263
2016-08-23 2016-08-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,436 228,772 -7.83 10.47 -203,538 2,395,746
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -25,000 248,208 -9.15 10.50 -262,500 2,606,184
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 273,208 10.07 7.69 192,250 2,100,970
2016-07-25 2016-07-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -18,286 248,208 -6.86 8.11 -148,230 2,012,024
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30,000 0 -100.00 3.25 -97,500
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -31,422 0 -100.00 4.49 -141,085
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -30,000 266,494 -10.12 7.48 -224,481 1,994,095
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 30,000 296,494 11.26 3.25 97,500 963,606
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,422 266,494 -10.55 7.48 -235,153 1,994,361
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 31,422 297,916 11.79 4.49 141,085 1,337,643
2016-06-23 2016-06-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,999 264,742 -8.31 7.28 -174,638 1,926,501
2016-05-25 2016-05-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -17,762 288,741 -5.80 8.08 -143,430 2,331,612
2016-05-02 2016-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -11,700 306,503 -3.68 7.13 -83,478 2,186,868
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -23,400 0 -100.00
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,400 318,203 7.94
2016-04-25 2016-04-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -21,409 294,803 -6.77 7.37 -157,864 2,173,789
2016-03-23 2016-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,834 316,212 -7.01 6.58 -156,871 2,081,244
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 0 -100.00
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 340,046 -1.57 6.47 -35,039 2,199,520
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 345,463 3.24
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 26,180 26,180
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 87,125 87,125
2016-03-03 2016-03-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,625 334,630 -2.80 6.12 -58,867 2,046,631
2016-03-03 2016-03-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -25,047 344,255 -6.78 6.00 -150,282 2,065,530
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 38,500 38,500
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -19,250 19,250 -50.00
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,250 369,302 5.50
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 29,333 -50.00
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 350,052 -4.02 4.81 -70,517 1,683,015
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 364,719 8.75
2015-09-28 2015-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 334,086 -2.55 6.46 -56,560 2,159,532
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 35,000 35,000
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 17,500 -50.00
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 342,836 5.38
2015-07-16 2015-07-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,000 325,336 -2.11 8.54 -59,797 2,779,150
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 0 -100.00
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 332,336 4.40
2015-04-30 2015-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 70,200 70,200
2015-04-27 2015-04-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -123,766 316,548 -28.11 9.50 -1,175,777 3,007,206
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 0 -100.00
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 440,314 -1.49 8.55 -57,016 3,765,565
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 446,981 3.07
2015-03-23 2015-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 433,648 -1.23 8.84 -47,910 3,835,313
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,657 0 -100.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 10,833 -50.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -20,657 440,314 -4.48 9.00 -185,913 3,962,826
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,657 460,971 4.69 7.56 156,167 3,484,941
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 439,065 2.53
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,036 31,422 -43.34
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,999 0 -100.00
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,036 428,232 -5.31 8.00 -192,288 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,036 452,268 5.61 4.49 107,922 2,030,683
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,999 428,232 -5.52 8.00 -199,992 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,999 453,231 5.84 2.62 65,497 1,187,465
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,334 58,666 -33.33
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 428,232 -3.31 6.33 -92,820 2,710,066
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,334 442,899 7.09
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 14,000 -50.00
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -4,564 413,565 -1.09 5.57 -25,421 2,303,557
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 418,129 3.46
2014-04-03 2014-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,500 403,028 -1.59 8.21 -53,337 3,307,127
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 409,528 3.28
2014-03-21 2014-03-21 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 394,377 -1.66 7.89 -52,583 3,110,451
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 13,333 -50.00
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 401,044 3.44
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,834 21,666 -33.34
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -3,442 387,711 -0.88 8.19 -28,190 3,175,353
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,834 391,153 2.85
2014-02-04 2014-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 88,000 88,000
2013-12-20 2013-12-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,750 380,319 -2.50 5.14 -50,115 1,954,840
2013-12-20 2013-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 390,069 5.26
2013-09-10 2013-09-06 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,449 370,451 -2.23 22.00 -185,878 8,149,922
2013-07-18 2013-07-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,000 378,900 -3.56 19.79 -277,045 7,498,014
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -28,000 28,000 -50.00
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 56,000 56,000
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 28,000 392,900 7.67
2013-04-03 2013-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,500 363,705 -1.76 18.04 -117,245 6,560,402
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 370,205 3.64
2013-03-26 2013-03-25 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -19,167 357,205 -5.09 18.87 -361,766 6,742,030
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 0 -100.00
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 376,372 11.34
2013-03-22 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,667 338,039 -1.93 19.46 -129,718 6,577,123
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,334 0 -100.00
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,334 344,706 4.02
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 32,500 32,500
2013-03-05 2013-03-04 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,838 331,372 -2.88 21.00 -206,598 6,958,812
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,631 17,262 -33.33
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -44,542 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -4,766 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,631 341,210 2.60 7.82 67,494 2,668,262
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 44,542 332,579 15.46 4.49 199,994 1,493,280
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 4,766 288,037 1.68 5.23 24,926 1,506,434
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -27,000 4,766 -85.00
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 27,000 282,940 10.55 5.23 141,210 1,479,776
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -8,142 255,940 -3.08 20.18 -164,306 5,164,869
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 264,082 7.97
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -1 24,999 0.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10,000 30,000 -25.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 1 244,170 0.00 2.62 3 639,725
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 244,169 4.27 3.25 32,500 793,549
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -36,843 0 -100.00
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -36,843 234,169 -13.59 20.00 -736,860 4,683,380
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 36,843 271,012 15.73 7.56 278,533 2,048,851
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -23,234 31,766 -42.24
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,234 234,169 -9.03 19.00 -441,446 4,449,211
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,234 257,403 9.92 5.23 121,514 1,346,218
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 233,778 -7.88 17.00 -340,000 3,974,226
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 253,778 8.56 7.44 148,800 1,888,108
2012-04-17 2012-04-17 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,111 233,778 -2.95 15.00 -106,665 3,506,670
2012-04-17 2012-04-13 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,600 240,889 -11.60 14.83 -468,628 3,572,384
2012-04-03 2012-04-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,200 272,489 -1.87 16.18 -84,134 4,408,763
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 26,000 -33.33
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 277,689 4.91
2012-04-03 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -26,061 264,689 -8.96 16.34 -425,876 4,325,415
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -7,500 0 -100.00
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 290,750 -2.51 16.00 -120,000 4,652,000
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 7,500 298,250 2.58 6.39 47,925 1,905,818
2012-03-26 2012-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -15,333 290,750 -5.01 15.41 -236,211 4,479,120
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 38,333 -50.00
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 306,083 14.32
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 40,000 40,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 82,000 82,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -36,400 267,750 -11.97 15.02 -546,622 4,020,829
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise 91,000 0 -100.00
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise -91,000 304,150 -23.03
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,449 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6,615 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,449 213,150 4.13 4.19 35,401 893,098
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 6,615 204,701 3.34 4.05 26,791 829,039
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16,500 16,500 -50.00
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41,551 8,449 -83.10
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -18,385 6,615 -73.54
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -76,436 119,882 -38.93 15.12 -1,155,781 1,812,724
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 16,500 196,318 9.18 3.90 64,350 765,640
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 41,551 179,818 30.05 4.19 174,099 753,437
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 18,385 138,267 15.34 4.05 74,459 559,981
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)